![Kevin Sun](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kevin Sun
Financieel Directeur/CFO bij DERMTECH, INC.
Vermogen: 84 803 $ op 31-05-2024
Profiel
Kevin Sun is currently the Chief Financial Officer, Secretary & Treasurer at DermTech, Inc. He previously worked as the Senior Manager-Financial Planning & Analysis at Alere San Diego, Inc. from 2004 to 2008.
From 2008 to 2018, he was the Vice President-Treasury & Controller at DexCom, Inc. He also held the position of Vice President-Finance at DermTech Operations, Inc. Additionally, he worked as the Senior Manager-Financial Planning & Analysis at Biosite, Inc. (Massachusetts) from 2004 to 2008.
Mr. Sun completed his undergraduate and graduate degrees at Kelley School of Business and holds an MBA.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
DERMTECH, INC.
0.77% | 10-06-2024 | 269 216 ( 0.77% ) | 84 803 $ | 31-05-2024 |
Actieve functies van Kevin Sun
Bedrijven | Functie | Begin |
---|---|---|
DERMTECH, INC. | Financieel Directeur/CFO | 12-09-2019 |
Eerdere bekende functies van Kevin Sun
Bedrijven | Functie | Einde |
---|---|---|
DEXCOM, INC. | Financieel Directeur/CFO | 01-09-2017 |
Alere San Diego, Inc.
![]() Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01-06-2008 |
Biosite, Inc. (Massachusetts) | Corporate Officer/Principal | 01-01-2008 |
DermTech Operations, Inc.
![]() DermTech Operations, Inc. Medical SpecialtiesHealth Technology DermTech Operations, Inc. engages in the provision of molecular dermatology. It develops products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments. The firm's products include adhesive skin collection kit, pigmented lesion assay (PLA), nevome, inflammatory disease and carcinome. The company was founded by Lawrence A. Rheins in 1996 and is headquartered in La Jolla, CA. | Financieel Directeur/CFO | - |
Opleiding van Kevin Sun
Kelley School of Business | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
DEXCOM, INC. | Health Technology |
DERMTECH, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Alere San Diego, Inc.
![]() Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | Health Technology |
Biosite, Inc. (Massachusetts) | |
DermTech Operations, Inc.
![]() DermTech Operations, Inc. Medical SpecialtiesHealth Technology DermTech Operations, Inc. engages in the provision of molecular dermatology. It develops products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments. The firm's products include adhesive skin collection kit, pigmented lesion assay (PLA), nevome, inflammatory disease and carcinome. The company was founded by Lawrence A. Rheins in 1996 and is headquartered in La Jolla, CA. | Health Technology |